# Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study)

> **NCT03391921** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Centre Hospitalier Universitaire Saint Pierre** · enrollment: 170 (actual)

## Conditions studied

- HPV - Anogenital Human Papilloma Virus Infection
- HIV Infections

## Interventions

- **BIOLOGICAL:** Vaccine

## Key facts

- **NCT ID:** NCT03391921
- **Lead sponsor:** Centre Hospitalier Universitaire Saint Pierre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-01-08
- **Primary completion:** 2023-05-02
- **Final completion:** 2028-05-02
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2025-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03391921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03391921, "Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03391921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*